The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements.
By R. Buchanan, J. Kreyenbuhl, D. Kelly, Jason Noel, D. Boggs, B. Fischer, S. Himelhoch, Beverly Fang, E. Peterson, Patrick R. Aquino and 1 more. Schizophrenia bulletin, 2010
833 citations recorded by the source corpus.
Subfields: Psychiatry and Mental health, Philosophy
View Paper: https://www.semanticscholar.org/paper/09ae63618f044886955a11b5d2f9c4b1706f3265
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Psychiatry and Mental health
Citations in the corpus
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance (2012, methodology): “First-episode schizophrenia patients should receive dosages at the lower end of the standard dose range (Buchanan et al. 2010; DGPPN 2006; Moore et al. 2007) .”
- Neuroscience and Biobehavioral Reviews Auditory Verbal Hallucinations as Atypical Inner Speech Monitoring, and the Potential of Neurostimulation as a Treatment Option (neutral): “However, it is well known that antipsychotic medication often causes undesirable side effects, such as weight gain and sedation (Buchanan et al., 2010).”